From the Triumvirate to the Ominous Octet: A New Paradigm for the Treatment of Type 2 Diabetes Mellitus
Author:
Affiliation:
1. From the Diabetes Division, University of Texas Health Science Center, San Antonio, Texas.
Publisher
American Diabetes Association
Subject
Endocrinology, Diabetes and Metabolism,Internal Medicine
Link
https://journals.org/diabetes/diabetes/article-pdf/58/4/773/303468/zdb00409000773.pdf
Reference309 articles.
1. Lilly Lecture: The triumvirate: β-cell, muscle, liver: a collusion responsible for NIDDM;DeFronzo;Diabetes,1988
2. The relationship of insulin response to a glucose stimulus over a wide range of glucose tolerance;Zimmet;Diabetologia,1978
3. Sequential changes in serum insulin concentration during development of non-insulin-dependent diabetes;Saad;Lancet,1989
4. Impaired glucose tolerance as a disorder of insulin action: longitudinal and cross-sectional studies in Pima Indians;Lillioja;N Engl J Med,1988
5. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic parents;Warram;Ann Intern Med,1990
Cited by 2241 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Synthesis, bioactivity, and molecular docking of pyrazole bearing Schiff-bases as prospective dual alpha-amylase and alpha-glucosidase inhibitors with antioxidant activity;Journal of Molecular Structure;2025-01
2. Diet and gut microbiome: Impact of each factor and mutual interactions on prevention and treatment of type 1, type 2, and gestational diabetes mellitus;Human Nutrition & Metabolism;2024-12
3. The interplay of extracellular vesicles in the pathogenesis of metabolic impairment and type 2 diabetes;Diabetes Research and Clinical Practice;2024-10
4. Genome-wide discovery and integrative genomic characterization of insulin resistance loci using serum triglycerides to HDL-cholesterol ratio as a proxy;Nature Communications;2024-09-14
5. Efficacy and safety of dapagliflozin add‐on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double‐blind, placebo‐controlled study;Diabetes, Obesity and Metabolism;2024-09-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3